Thus, the role of Mbd2 in controlling the CD4 and Ifng immune response is likely to be of great interest because ‘tumour‐promoting inflammation’ is now identified as an enabling characteristic in the hallmarks of cancer47. The gene discussed is MBD2; the disease is neoplasm.